NexLife
Flat-rate compounded GLP-1 telehealth — transparent 503A & 503B pharmacy sourcing, MD/DO oversight, included labs
Independent, methodology-driven reviews of every GLP-1 telehealth provider we cover. Rankings reflect pricing transparency, clinical oversight, pharmacy quality, support, and patient outcomes.
Flat-rate compounded GLP-1 telehealth — transparent 503A & 503B pharmacy sourcing, MD/DO oversight, included labs
Brand-name Wegovy & Zepbound with insurance navigation — for patients with commercial coverage who want the FDA-approved pathway
Obesity-medicine specialist program with registered dietitians — clinical depth at a fixed program fee
Flat-rate compounded GLP-1 with transparent pricing — established compounded program with broad state coverage
Insurance-pathway program with obesity-medicine clinicians — strong for insured patients seeking brand-name access
Mass-market consumer brand with broad GLP-1 access — mature platform, competitive pricing, less clinical specialization
WeightWatchers Clinic — insurance-pathway brand-name GLP-1 with WW behavioral framework
Coaching-forward GLP-1 program — strong on behavioral support, less on pricing transparency
General primary-care telehealth with GLP-1 prescribing — broad practice scope, less weight-management specialization
Budget compounded GLP-1 entry — lowest published entry price, less clinical depth and pharmacy disclosure
Consumer behavioral-app brand layered with GLP-1 prescribing — strong app, less clinical depth
Premium 12-month structured weight-loss program — highest price point, most structured curriculum
We score each provider across six equally-weighted dimensions: pricing & value, clinical depth, transparency, patient support, trust & track record, and user experience. We do not accept payment for higher rankings. See our full methodology.
NexLife is our 2026 editor's pick. The most aggressive value proposition among physician-led GLP-1 programs, combining $199/mo flat-rate compounded sema, LegitScript certification, and physician-led oversight under Dr. Adam Kennah, MD. Visit NexLife or read our full review.